Queens Park: Breast Cancer Canada Calls on Ontarians
Self-Refer for Mammograms as Screening Age Lowers to 40 This pivotal change expands access to life-saving mammograms for millions of women in Ontario, empowering them to make informed health decisions and detect cancers at their most treatable stage. From left to right: Shaniah Leduc (Board Chair, Breast Cancer Canada), MPP Laura Smith, and Kimberly Carson […]
Cortney & Connie: Twin sisters carrying the BRCA2 Gene
This year alone, more than 30,000 Canadians are expected to be diagnosed with breast cancer. My journey began in 2015, when I was just 29 years old. A lump under my left armpit initially seemed insignificant, but when pain emerged, my mom insisted I visit the hospital. That visit resulted in a diagnosis of Stage […]
Manitoba removing barriers for breast screening
Manitoba is taking a significant step forward in breast cancer care with a new plan to lower the age for self-referral mammogram screenings. Currently, women under 50 need a doctor’s referral to access a mammogram. However, this is about to change. The province has committed to lowering the self-referral age to 45 by the end […]
New Survey Reveals 94% of Canadians Back Earlier Screening
A Call for Equitable Access to Breast Cancer Care Nationwide Today, Breast Cancer Canada (BCC), a national charity dedicated to saving lives through breast cancer research, released new data revealing an overwhelming national demand for earlier breast cancer screening. The survey also highlights the deep impact of delayed screening and the need for more equitable […]
Physical Activity in Breast Cancer Care
For many Canadians facing a breast cancer diagnosis, the journey is filled with both physical and emotional challenges. While treatments like chemotherapy, surgery, and radiation are crucial, research presented at the ESMO Congress 2024 emphasizes another vital component of care: physical activity. Staying active during and after breast cancer treatment not only improves quality of […]
Breast Cancer Canada Shares Key Updates from the 2024 ESMO Congress in Barcelona
The 2024 ESMO Congress has highlighted significant advances in breast cancer research, aligning with Breast Cancer Canada’s mission to improve patient outcomes. Here are key findings from the congress that could shape the future of breast cancer treatment. NATALEE Trial: A Step Forward in Early HR+ Breast Cancer Treatment One of the major highlights is the […]
Breast Cancer Research at ESMO Congress 2024
The ESMO Congress 2024 is currently underway in Barcelona, serving as a global hub for the latest advancements in oncology. Researchers, healthcare professionals, and press representatives from around the world have gathered to discuss cutting-edge data and emerging hot topics in cancer care. This year, some of the most compelling findings offer new hope for […]
Reporting Live from ESMO 2024
Global Collaboration for Improved Patient Outcomes Breast Cancer Canada is proud to be at the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, where the latest global advances in cancer treatment and research are being unveiled. Our presence at this prestigious conference allows us to engage with the world’s leading oncologists, researchers, and […]
Breast Cancer Canada Shines a Light on Women’s Health at Connexions to Health Equity Summit
At this week’s Connexions to Health Equity Summit, held by the Ontario Chamber of Commerce at the Sheraton Centre Toronto, Kimberly Carson, CEO of Breast Cancer Canada, delivered a compelling and urgent message about the need for progress in women’s health. The event, partnered with Pfizer Canada, focused on a range of crucial topics, highlighting […]
Breast Cancer Canada at CDA Symposium
Last week, Breast Cancer Canada had the privilege of participating in the Canada’s Drug Agency (CDA) Symposium 2024, held both in-person at the Ottawa Shaw Centre and virtually. The event, themed “From Disruption to Opportunity: Embracing Change in Health Care,” brought together a diverse group of leaders from policy, industry, health technology assessment, patient advocacy, […]
